Basit öğe kaydını göster

Comparison of Ga-68-DOTATATE and Ga-68-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

dc.contributor.authorUslu, Ilhami
dc.contributor.authorOcak, Meltem
dc.contributor.authorAraman, Ahmet
dc.contributor.authorDemirci, Emre
dc.contributor.authorKabasakal, Levent
dc.contributor.authorDecristoforo, Clemens
dc.contributor.authorKanmaz, Bedii
dc.contributor.authorOzsoy, Yildiz
dc.date.accessioned2021-03-03T20:00:12Z
dc.date.available2021-03-03T20:00:12Z
dc.date.issued2012
dc.identifier.citationKabasakal L., Demirci E., Ocak M., Decristoforo C., Araman A., Ozsoy Y., Uslu I., Kanmaz B., "Comparison of Ga-68-DOTATATE and Ga-68-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.39, sa.8, ss.1271-1277, 2012
dc.identifier.issn1619-7070
dc.identifier.otherav_578c0193-d462-4c23-b342-d13ba98b2040
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/61742
dc.identifier.urihttps://doi.org/10.1007/s00259-012-2123-y
dc.description.abstractRecent studies have suggested that positron emission tomography (PET) imaging with Ga-68-labelled DOTA-somatostatin analogues (SST) like octreotide and octreotate is useful in diagnosing neuroendocrine tumours (NETs) and has superior value over both CT and planar and single photon emission computed tomography (SPECT) somatostatin receptor scintigraphy (SRS). The aim of the present study was to evaluate the role of Ga-68-DOTA-1-NaI3-octreotide (Ga-68-DOTANOC) in patients with SST receptor-expressing tumours and to compare the results of Ga-68-DOTA-D-Phe(1)-Tyr(3)-octreotate (Ga-68-DOTATATE) in the same patient population.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectNükleer Tıp
dc.subjectDahili Tıp Bilimleri
dc.titleComparison of Ga-68-DOTATATE and Ga-68-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
dc.contributor.departmentMedical University of Innsbruck , ,
dc.identifier.volume39
dc.identifier.issue8
dc.identifier.startpage1271
dc.identifier.endpage1277
dc.contributor.firstauthorID12566


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster